Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide

Area of Science:

• Immunology
• Neuroscience
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSC) exhibit immunoregulatory properties.
• Microglia play a key role in central nervous system (CNS) inflammatory responses.

Purpose of the Study:

• To investigate the modulatory effects of mouse bone marrow-derived MSC on BV2 microglia proliferation, nitric oxide (NO) production, and CD40 expression.
• To understand the potential of MSC in moderating neuroinflammatory processes.

Main Methods:

• Co-culture of mouse bone marrow MSC with BV2 microglia at various seeding densities.
• Activation of microglia using lipopolysaccharide (LPS).
• Measurement of microglia proliferation, NO production, and CD40 expression.

Main Results:

• MSC exerted a dose-dependent anti-proliferative effect on both untreated and LPS-treated microglia.
• MSC significantly reduced BV2 microglia proliferation at ratios of 1:0.2 and 1:0.1.
• MSC produced NO when stimulated by soluble factors from LPS-activated BV2 cells, with higher MSC numbers increasing NO levels.
• MSC decreased the expression of the co-stimulator molecule CD40 on microglia.
• NO did not appear to mediate the observed suppression of microglia proliferation.

Conclusions:

• MSC possess regulatory effects on microglia, including inhibition of proliferation and CD40 expression.
• MSC can produce NO in response to activated microglia, indicating a role in modulating CNS inflammation.
• MSC-derived modulation of microglia suggests therapeutic potential for neuroinflammatory conditions.